Abstract
Thioridazine toxicity has been described as a 'progressive chorioretinopathy', but this designation can be misleading. During the first year after thioridazine exposure retinal pigmentation evolves from a granular to a patchy or nummular appearance. However, visual function and the electroretinogram typically improve during this period. Some cases may show chorioretinal atrophy and functional loss many years later, but there is little evidence for ongoing drug-related progression. Late atrophy may represent degeneration of cells that were injured subclinically at the time of initial drug exposure. Although thioridazine toxicity produces an evolving pigmentary disturbance, functional changes must be monitored independently of fundus appearance.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brinkley J. R., Jr, Dubois E. L., Ryan S. J. Long-term course of chloroquine retinopathy after cessation of medication. Am J Ophthalmol. 1979 Jul;88(1):1–11. doi: 10.1016/0002-9394(79)90743-8. [DOI] [PubMed] [Google Scholar]
- CONNELL M. M., POLEY B. J., MCFARLANE J. R. CHORIORETINOPATHY ASSOCIATED WITH THIORIDAZINE THERAPY. Arch Ophthalmol. 1964 Jun;71:816–821. doi: 10.1001/archopht.1964.00970010832007. [DOI] [PubMed] [Google Scholar]
- Davidorf F. H. Thioridazine pigmentary retinopathy. Arch Ophthalmol. 1973 Sep;90(3):251–255. doi: 10.1001/archopht.1973.01000050253014. [DOI] [PubMed] [Google Scholar]
- Ehrenfeld M., Nesher R., Merin S. Delayed-onset chloroquine retinopathy. Br J Ophthalmol. 1986 Apr;70(4):281–283. doi: 10.1136/bjo.70.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kozy D., Doft B. H., Lipkowitz J. Nummular thioridazine retinopathy. Retina. 1984 Fall-Winter;4(4):253–256. doi: 10.1097/00006982-198400440-00008. [DOI] [PubMed] [Google Scholar]
- Meredith T. A., Aaberg T. M., Willerson W. D. Progressive chorioretinopathy after receiving thioridazine. Arch Ophthalmol. 1978 Jul;96(7):1172–1176. doi: 10.1001/archopht.1978.03910060006002. [DOI] [PubMed] [Google Scholar]
- Morgan C. M., Schatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology. 1989 Jan;96(1):96–103. doi: 10.1016/s0161-6420(89)32924-1. [DOI] [PubMed] [Google Scholar]
- Ogawa S., Kurumatani N., Shibaike N., Yamazoe S. Progression of retinopathy long after cessation of chloroquine therapy. Lancet. 1979 Jun 30;1(8131):1408–1408. doi: 10.1016/s0140-6736(79)92044-0. [DOI] [PubMed] [Google Scholar]
- POTTS A. M. The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol. 1962 Aug;1:522–530. [PubMed] [Google Scholar]
- Potts A. M. Drug-induced macular disease. Trans Am Acad Ophthalmol Otolaryngol. 1966 Nov-Dec;70(6):1054–1057. [PubMed] [Google Scholar]
- Sassani J. W., Brucker A. J., Cobbs W., Campbell C. Progressive chloroquine retinopathy. Ann Ophthalmol. 1983 Jan;15(1):19–22. [PubMed] [Google Scholar]